Subscribe To
Heartflow, longview acquisition spac deal called off
HeartFlow Holding Inc and a special purpose acquisition company, Longview Acquisition Corp II (NYSE: LGV), have called off merger plans that woul...
February 7, 2022, 6:00 am
Will irhythm technologies stock continue to see higher levels after a 20% rally in a month?
The stock price of iRhythm Technologies, a healthcare company that provides ambulatory electrocardiogram and c...
January 24, 2022, 7:00 am
Will irhythm technologies stock continue to see higher levels after a 20% rally in a month?
The stock price of iRhythm Technologies, a healthcare company that provides ambulatory electrocardiogram and c...
January 24, 2022, 7:00 am
Will irhythm technologies stock continue to see higher levels after a 20% rally in a month?
The stock price of iRhythm Technologies, a healthcare company that provides ambulatory electrocardiogram and c...
January 24, 2022, 7:00 am
Abiomed (abmd) reports positive data backing precardia system
Abiomed's (ABMD) preCARDIA system has proven to be effective in reducing cardiac filling pressures and ...
January 19, 2022, 1:05 pm
Abiomed (abmd) reports positive data backing precardia system
Abiomed's (ABMD) preCARDIA system has proven to be effective in reducing cardiac filling pressures and ...
January 19, 2022, 1:05 pm
Abiomed (abmd) reports positive data backing precardia system
Abiomed's (ABMD) preCARDIA system has proven to be effective in reducing cardiac filling pressures and ...
January 19, 2022, 1:05 pm
Angion (angn) kidney drug misses third study goal in 2021
Angion's (ANGN) phase II study evaluating ANG-3777 in cardiac surgery-associated acute kidney injury fa...
December 13, 2021, 1:50 pm
Angion (angn) kidney drug misses third study goal in 2021
Angion's (ANGN) phase II study evaluating ANG-3777 in cardiac surgery-associated acute kidney injury fa...
December 13, 2021, 1:50 pm
Angion (angn) kidney drug misses third study goal in 2021
Angion's (ANGN) phase II study evaluating ANG-3777 in cardiac surgery-associated acute kidney injury fa...
December 13, 2021, 1:50 pm
Zynex to display its cm-1500 fluid monitoring system at the american society of anesthesiologists annual conference
ENGLEWOOD, Colo., Oct. 8, 2021 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture a...
October 8, 2021, 9:15 am
Zynex to display its cm-1500 fluid monitoring system at the american society of anesthesiologists annual conference
ENGLEWOOD, Colo., Oct. 8, 2021 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture a...
October 8, 2021, 9:15 am
Zynex to display its cm-1500 fluid monitoring system at the american society of anesthesiologists annual conference
ENGLEWOOD, Colo., Oct. 8, 2021 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture a...
October 8, 2021, 9:15 am
Biotricity launches biocare cardiac application for samsung's galaxy watch4 series
REDWOOD CITY, CA / ACCESSWIRE / October 7, 2021 / Biotricity Inc. (NASDAQ: BTCY), a medical diagnostic and consumer healthcare technology company, to...
October 8, 2021, 8:16 am
Biotricity launches biocare cardiac application for samsung's galaxy watch4 series
REDWOOD CITY, CA / ACCESSWIRE / October 7, 2021 / Biotricity Inc. (NASDAQ: BTCY), a medical diagnostic and consumer healthcare technology company, to...
October 8, 2021, 8:16 am
Biotricity launches biocare cardiac application for samsung's galaxy watch4 series
REDWOOD CITY, CA / ACCESSWIRE / October 7, 2021 / Biotricity Inc. (NASDAQ: BTCY), a medical diagnostic and consumer healthcare technology company, to...
October 8, 2021, 8:16 am
Cytosorbents announces availability of preliminary data abstracts from two endocarditis studies, including the remove study, to be presented at the eacts conference
MONMOUTH JUNCTION, N.J., Oct. 7, 2021 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening condi...
October 7, 2021, 3:11 pm
Cytosorbents announces availability of preliminary data abstracts from two endocarditis studies, including the remove study, to be presented at the eacts conference
MONMOUTH JUNCTION, N.J., Oct. 7, 2021 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening condi...
October 7, 2021, 3:11 pm
Cytosorbents announces availability of preliminary data abstracts from two endocarditis studies, including the remove study, to be presented at the eacts conference
MONMOUTH JUNCTION, N.J., Oct. 7, 2021 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening condi...
October 7, 2021, 3:11 pm